17-50482196-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_018346.3(RSAD1):c.580G>C(p.Val194Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018346.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RSAD1 | NM_018346.3 | c.580G>C | p.Val194Leu | missense_variant | 4/9 | ENST00000258955.7 | NP_060816.1 | |
RSAD1 | NR_130911.2 | n.266G>C | non_coding_transcript_exon_variant | 2/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RSAD1 | ENST00000258955.7 | c.580G>C | p.Val194Leu | missense_variant | 4/9 | 1 | NM_018346.3 | ENSP00000258955 | P1 | |
RSAD1 | ENST00000506211.1 | c.100G>C | p.Val34Leu | missense_variant, NMD_transcript_variant | 1/6 | 3 | ENSP00000422893 | |||
RSAD1 | ENST00000515221.2 | c.241G>C | p.Val81Leu | missense_variant, NMD_transcript_variant | 2/5 | 2 | ENSP00000424558 | |||
RSAD1 | ENST00000504284.1 | c.*99G>C | 3_prime_UTR_variant, NMD_transcript_variant | 3/8 | 5 | ENSP00000425372 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2021 | The c.580G>C (p.V194L) alteration is located in exon 4 (coding exon 4) of the RSAD1 gene. This alteration results from a G to C substitution at nucleotide position 580, causing the valine (V) at amino acid position 194 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.